IL6 and diabetes mellitus: Consequently, the significant reduction in the expression of IGFBP-3 and IL-6, as a result of the inhibitory effects of these metabolites, leads to the emergence of abnormal blood glucose levels and the accompanying vasculopathy during the occurrence of diabetes in this study.